BackArena Pharmaceuticals Overview

Arena Pharmaceuticals Other Current Assets

Track Arena Pharmaceuticals's other current assets ($19M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$19.00M
46.14% YoYΔ $-16.27M vs prior year quarter

Peer average / median

Loading

Arena Pharmaceuticals Other Current Assets History

Loading

Arena Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

Arena Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arena Pharmaceuticals (ARNA) FAQ

Arena Pharmaceuticals (ARNA) currently reports a other current assets of $19M as of December 2021. That compares with $35M in the prior-year period — down 46.1% year over year. Use the charts on this page to explore Arena Pharmaceuticals's other current assets history and peer comparisons.

Arena Pharmaceuticals's other current assets decreased from $35M to $19M — a 46.1% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arena Pharmaceuticals reported $19M in other current assets as of December 2021. That compares with $35M in the prior-year period — down 46.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arena Pharmaceuticals, and consider following ARNA for alerts when major investors trade the stock.

Arena Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARNA with unrelated industries.